Moreover, BAP1 mutations occur in ~15% of clear cell renal cell carcinomas (CCRCC), and patients bearing such mutations have a particularly poor prognosis relative to other common molecular subtypes of CCRCC [57]. This evidence concerns the gene BAP1 and nonpapillary renal cell carcinoma.